All In MedTech

Device Trial Radar · NCT01113658

Clinical Evaluation of the SNaP Wound Care System

Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System

Last checked: Nov 20, 2026Latest source record: Aug 1, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Mar 2010

Primary completion

Apr 2014

Study completion Aug 2014

Sponsor

Lead sponsor
3MNot on our public-company list
Sponsor type
Industry
First posted
Apr 30, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the efficacy of design improvements of the Spiracur SNaP Wound Care System. This study prospectively evaluates the safety and efficacy of current and new design iterations of components of the FDA-cleared Spiracur SNaP Wound Care System in order to optimize safety, efficacy, and system performance.

Conditions

  • Acute and Chronic Wounds
  • Pressure Ulcers
  • Trauma Wounds
  • Diabetic Foot Ulcers
  • Venous Stasis Ulcers

Interventions

  • SNaP Wound Care SystemDevice

    The intervention is negative pressure wound therapy (NPWT) with the Spiracur SNaP Wound Care system for the treatment of a variety of acute and chronic wounds including pressure ulcers, trauma wounds, diabetic foot ulcers, venous stasis ulcers, and skin grafts. The Spiracur SNaP Wound Care system weighs less than 4 ounces, does not utilize an electric pump (device has no electrically powered parts), is fully disposable after use, and is designed for particularly small chronic wounds that require advanced wound care management. It delivers NPWT at a constant pressure level over several days without any required adjustments by the patient or clinician.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Frequency of complaints about device use and operationTime frame: 16 weeks

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • San Francisco Center for Advanced Wound Care

    Daly City, California

  • The SF Center For Advanced Wound Care At

    Daly City, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.